The present invention relates generally to the field of immunodiagnostic assays, and more specifically to devices and methods for addressing sensitivity limitations of present immunodiagnostic assays.
This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present invention, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of various aspects of the present invention. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.
Immunodiagnostic assays include biochemical tests that report or measure the presence or concentration of a macromolecule or a small molecule in a sample. Many immunodiagnostic assays typically use antibodies and gold conjugates or florescent tags to indicate the presence of a target antigens (the molecule of interest/analyte of interest). A common type of immunodiagnostic assay utilizes a lateral flow assay device, such as the pregnancy test strip, as well as other lateral flow assays devices to detect for diseases (Legionella, influenza, C. Difficile, etc.). However, sensitivity is a problem for immunodiagnostics, as well as other rapid diagnostic tests (enzymatic or aptamer-based sensors), since the sample fluid is often dilute and thus the concentration of the analyte of interest may fall below the limit of detection of these devices.
These sensitivity limitations may be overcome by pretreating the sample to increase the antigen concentration while simultaneously decreasing the amount of interferents, such as large molecules like proteins (e.g. mucins, serum, etc.), small molecules (e.g. salt, etc.), and other interferents (e.g., pH). Such sample pretreatment is typically done with conventional laboratory processes (e.g. centrifugation, buffering, lipid scrubbing, pH, etc.) that require multi-step processes with equipment that is not compatible with a rapid and portable test format. Portable sample pretreatment for rapid diagnostics depends on developing processes that are automatic and passively driven with as few steps as possible
Most sample pretreatment can be done through a series of filtration membranes, which is broadly illustrated in the device 10 shown in
Devices and methods of sample pretreatment that can operate according to principles similar to those shown in
Certain exemplary aspects of the invention are set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of certain forms the invention might take and that these aspects are not intended to limit the scope of the invention. Indeed, the invention may encompass a variety of aspects that may not be explicitly set forth below.
Various aspects of the present invention overcome the drawbacks described above in the Background of the Invention section. These aspects do so by providing hydrogel-based or aerogel-based devices and methods for pretreatment of a sample. The devices may include an aerogel-based device for pretreating a sample comprising at least one aerogel; a hydrogel-based device for pretreating a sample comprising at least one hydrogel; or a combination aerogel-based and hydrogel-based device for pretreating a sample comprising at least one aerogel in fluid communication with at least one hydrogel. The methods of pretreating a sample may include contacting a fluid sample with an aerogel or a hydrogel, wherein said aerogel or said hydrogel includes (i) a filter layer, and (ii) a fluid storage layer.
Additional aspects of the present invention may include methods of making devices for pretreating a sample. Such methods may include positioning a first hydrogel and a second hydrogel adjacent to one another, wherein the density of the first hydrogel is different from the density of the second hydrogel; and removing water from the first hydrogel and the second hydrogel to form an aerogel, said aerogel including a first layer and a second layer.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and, together with the general description of the invention given above and the detailed description of the embodiments given below, serve to explain the principles of the present invention.
“Aerogel,” as used herein, means a porous polymer or synthetic matrix derived from a gel (e.g., hydrogel) wherein the liquid has been replaced with a gas.
“Sample pretreatment,” as used herein, means processing done to a sample of fluid to concentrate (e.g., concentrate an analyte of interest), add reagents, buffer, or remove interferents.
“Immunodiagnostic assays,” as used herein, means biochemical tests that report or measure the presence or concentration of a macromolecule or a small molecule in a solution, as may be done through the use of an antibody or an antigen.
“Rapid diagnostic test,” as used herein, means a medical diagnostic test that is quick and easy to perform, (also known as point-of-care). It may include immunodiagnostic and other enzymatic sensors (e.g. glucose).
“Membrane,” as used herein, means a selective barrier that acts as a boundary for molecules, ions, proteins, or other small particles. Membranes may be size selective or charge selective.
One or more specific embodiments of the present invention will be described below. In an effort to provide a concise description of these embodiments, all features of an actual implementation may not be described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such a development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
Various aspects of the present invention overcome the drawbacks described above in the Background of the Invention section. As described in the Background, presently sample pretreatment (such as filtration to concentrate an analyte of interest) is typically done with conventional laboratory processes that require multi-step processes with equipment that is not compatible with a rapid and portable test format. For example, the driving mechanism of membrane filtration typically requires a pump, which is not amenable to rapid diagnostics. Embodiments of the present invention, however, are based on the use of hydrogels, or hydrogels with the water removed (also known as an aerogels), as a wick, membrane, and/or device containing antibodies to an analyte of interest.
Hydrogels include a network of polymers or synthetic materials that are highly absorbent and contain a substantial amount of water (e.g., over 90% water). Some examples of hydrogels are agarose, sodium polyacrylate, poly(vinyl alcohol), Poly(ethylene glycol), etc., but they can also be synthetic materials (e.g. silica, carbon, metal oxide). The density of hydrogels can be controlled by increasing the concentration of the material (in the case of agarose) or by increasing the crosslink agent that creates the network. The density of hydrogel is frequently used in molecular biology for the separation of molecules including DNA electrophoresis and protein purification.
One aspect of the present invention involves the removal of water from a hydrogel using freeze-dried or solvent exchange techniques while the integrity of the polymeric structure remains to form an aerogel. The aerogel then can act simultaneously as a wick and size-exclusion membrane when exposed to the sample. For example, an agarose (2 wt %) typically contains pore sizes ranging from 100-200 nm. If the agarose is freeze-dried and the structure retained, it will readily absorb water while filtering out particles larger than 200 nm. The aerogel thus acts both as a membrane and a driving wick. An embodiment in accordance with this aspect of the present invention is illustrated in
Referring now to
Referring now to
To leverage the properties of such “smart” hydrogels, the embodiment shown in
Once the fluid sample has contacted and rehydrated the aerogel, an external stimulus is applied (e.g. pH change or ionic concentration) that causes the hydrogel to contract 54. When this occurs, the hydrogel pores reduce in size during the dynamic shift, causing the analytes to be rejected and remain inside of the matrix. The solution in the hydrogel thus becomes concentrated. And the hydrogel beads can be read directly using a reporter or used for further processing.
Referring now to
The embodiments of the present invention recited herein are intended to be merely exemplary and those skilled in the art will be able to make numerous variations and modifications to it without departing from the spirit of the present invention. Notwithstanding the above, certain variations and modifications, while producing less than optimal results, may still produce satisfactory results. All such variations and modifications are intended to be within the scope of the present invention as defined by the claims appended hereto.
This application claims priority to and the benefit of the filing date of U.S. Provisional Patent Application Ser. No. 62/681,895, entitled “Methods and Devices for Hydrogel- and Aerogel-Based Sample Pretreatment,” filed Jun. 7, 2018, the disclosure of which is incorporated by reference herein in its entirety.
This invention was made with government support under Grant No. 1013160 awarded by the Ohio Federal Research Network. The government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/035999 | 6/7/2019 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62681895 | Jun 2018 | US |